Simple jQuery Dropdowns
Please use this identifier to cite or link to this item: http://repository.li.mahidol.ac.th/dspace/handle/123456789/32468
Title: Malaria Burden and Artemisinin Resistance in the Mobile and Migrant Population on the Thai-Myanmar Border, 1999-2011: An Observational Study
Authors: Verena I. Carrara
Khin Maung Lwin
Aung Pyae Phyo
Elizabeth Ashley
Jacher Wiladphaingern
Kanlaya Sriprawat
Marcus Rijken
Machteld Boel
Rose McGready
Stephane Proux
Cindy Chu
Pratap Singhasivanon
Nicholas White
François Nosten
Shoklo Malaria Research Unit
Mahidol Oxford Research Unit
University of Oxford
University Medical Center Utrecht
Academic Medical Centre, University of Amsterdam
Mahidol University
Keywords: Medicine
Issue Date: 1-Mar-2013
Citation: PLoS Medicine. Vol.10, No.3 (2013)
Abstract: Background: The Shoklo Malaria Research Unit has been working on the Thai-Myanmar border for 25 y providing early diagnosis and treatment (EDT) of malaria. Transmission of Plasmodium falciparum has declined, but resistance to artesunate has emerged. We expanded malaria activities through EDT and evaluated the impact over a 12-y period. Methods and Findings: Between 1 October 1999 and 30 September 2011, the Shoklo Malaria Research Unit increased the number of cross-border (Myanmar side) health facilities from two to 11 and recorded the number of malaria consultations. Changes in malaria incidence were estimated from a cohort of pregnant women, and prevalence from cross-sectional surveys. In vivo and in vitro antimalarial drug efficacy were monitored. Over this period, the number of malaria cases detected increased initially, but then declined rapidly. In children under 5 y, the percentage of consultations due to malaria declined from 78% (95% CI 76-80) (1,048/1,344 consultations) to 7% (95% CI 6.2-7.1) (767/11,542 consultations), p<0.001. The ratio of P. falciparum/P. vivax declined from 1.4 (95% CI 1.3-1.4) to 0.7 (95% CI 0.7-0.8). The case fatality rate was low (39/75,126; 0.05% [95% CI 0.04-0.07]). The incidence of malaria declined from 1.1 to 0.1 episodes per pregnant women-year. The cumulative proportion of P. falciparum decreased significantly from 24.3% (95% CI 21.0-28.0) (143/588 pregnant women) to 3.4% (95% CI 2.8-4.3) (76/2,207 pregnant women), p<0.001. The in vivo efficacy of mefloquine-artesunate declined steadily, with a sharp drop in 2011 (day-42 PCR-adjusted cure rate 42% [95% CI 20-62]). The proportion of patients still slide positive for malaria at day 3 rose from 0% in 2000 to reach 28% (95% CI 13-45) (8/29 patients) in 2011. Conclusions: Despite the emergence of resistance to artesunate in P. falciparum, the strategy of EDT with artemisinin-based combination treatments has been associated with a reduction in malaria in the migrant population living on the Thai-Myanmar border. Although limited by its observational nature, this study provides useful data on malaria burden in a strategically crucial geographical area. Alternative fixed combination treatments are needed urgently to replace the failing first-line regimen of mefloquine and artesunate. Please see later in the article for the Editors' Summary. © 2013 Carrara et al.
URI: https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84875419985&origin=inward
http://repository.li.mahidol.ac.th/dspace/handle/123456789/32468
ISSN: 15491676
15491277
Appears in Collections:Scopus 2011-2015

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.